April - 2023
| Previous Next | Showing Journal 5 of 6 |
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19E Goligher, P Lawler, T Jensen et al JAMA, 2023, online first This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
April |
Previous Comments
No Comments yet.
Comment
The use of therapeutic-dose heparin in patients hospitalized for moderate or severe COVID-19 is of ongoing interest, with multiple RCTs reporting varied outcomes. In particular, the signal of benefit in non-critically ill hospitalised patients and no-benefit in critically ill patients,...